Innovate4Outcomes®: Patient Advocates Come to the Table
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...
With COVID-19 still impacting provider facetime for brand field teams, life sciences organizations need new ways to deliver information that supports HCP awareness. That’s...
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights from this year’s...
Like any prescribing HCP, I, as a nurse practitioner, recognized that making medication decisions was one of the biggest choices I had to make for patients. My choice had a...
How to support patients throughout their entire care journey is an ongoing topic of conversation in the healthcare community and one we are constantly trying to improve upon...
Patient engagement is at the forefront of what I do every day as the Vice President of Patient Engagement at OptimizeRx, so when I had the opportunity to participate in ...